Predictors of Pulmonary Edema in Severe Preeclampsia

Status Not yet recruiting

Clinical Trial Summary

Pre-eclampsia is a multisystem major cardiovascular disease of pregnancy with hypertension its main clinical manifestation. Acute pulmonary edema, which signifies severe disease, is a leading cause of death in women with pre-eclampsia, and is a frequent cause for admission to an intensive care unit

Clinical Trial Description

Outside pregnancy, transthoracic cardiac ultrasound (echocardiography) and lung ultrasound have become important diagnostic and monitoring tools in critically ill patients. Echocardiography allows a rapid and non-invasive assessment of myocardial contractility and preload, and lung ultrasound can be used to determine the amount of extravascular lung water (EVLW). In pregnancy, there is evidence of a good correlation between non-invasive hemodynamic monitoring by echocardiography and invasive monitoring using a pulmonary artery catheter. Previous studies have shown that invasive hemodynamic monitoring could facilitate fluid management in patients with PE. However, recent studies have examined the utility of echocardiography in combination with lung ultrasound for guiding fluid therapy in patients with severe PE. Thoracic fluid content (TFC) is one of the many variables measured by the ICON electrical cardiometry (EC) device (Osypka Medical, etc.). The ICON device is one relatively new proprietary implementation of impedance cardiography technology, which is also often called "thoracic electrical bio-impedance". Impedance cardiography is based on measuring the changes in total resistance of the thorax to electric current. The impedance (Zo) to electric current is determined by the resistance of different tissues such as bone, muscles, and fluids. The fluid compartment is considered the dynamic component that will cause short term changes in thoracic impedance. TFC is calculated as the reciprocal of the total thoracic impedance (1/ Zo) and is considered a numerical measure of total (intravascular and extravascular) thoracic fluid. Although TFC is a measure of both extra and intra-vascular thoracic fluid, the investigators hypothesized that it might provide an estimate of the increase in intrathoracic fluids such as to facilitate the risk of pulmonary edema. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05095974
Study type	Observational
Source	Assiut University
Contact
Status	Not yet recruiting
Phase
Start date	October 30, 2021
Completion date	December 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02638649` - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT02105298` - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)	N/A
Withdrawn	`NCT04537975` - C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19	N/A
Recruiting	`NCT05276219` - Optimized Treatment of Pulmonary Edema or Congestion	Phase 4
Withdrawn	`NCT04508933` - Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients
Recruiting	`NCT03728491` - Education and Training Competences in Thoracic Ultrasound	N/A
Recruiting	`NCT04115514` - Treatment of ARDS With Instilled T3	Phase 2
Completed	`NCT01940328` - Measurements of Doppler Signals Noninvasively From the Lung in Congestive Heart Failure	N/A
Withdrawn	`NCT01713595` - Safety Study of Inhaled Saline in Acute Lung Injury	Phase 1
Completed	`NCT00554580` - Continuous Positive Airway Pressure for Acute Pulmonary Edema	Phase 3
Withdrawn	`NCT03942055` - The Association of B-7 Lung Ultrasound Pattern With the Development of Postoperative Pulmonary Edema
Active, not recruiting	`NCT03767803` - Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Recruiting	`NCT05662995` - Point-of-care Ultrasound Abnormalities in Early Onset Preeclampsia	N/A
Completed	`NCT00289276` - FAST (Fluid Accumulation Status Trial)	N/A
Enrolling by invitation	`NCT06107465` - High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema	Phase 2/Phase 3
Recruiting	`NCT05636631` - Chest U/S in Differentiating Lung Congestion & Pneumonia in Adult Critically-ill Patients and Its Prognostic Impact
Not yet recruiting	`NCT05222711` - The Use of a Monitoring Device by General Practitioners During Out-of-hours Care	N/A
Recruiting	`NCT02753023` - Registry Of Acute meDical Emergencies in Brazil
Recruiting	`NCT01269177` - Mortality and Risk Factors in Patients With Acute Cardiogenic Pulmonary Edema: a Multicentric, Observational, Prospective Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.